Document is current
Any future updates will be listed below
-
Authors
Jiang, Huiqi
Holm, Jonas
Vidlund, Mårten
Vanky, Farkas
Friberg, Örjan
Yang, Yanqi
Svedjeholm, Rolf http://orcid.org/0000-0002-9945-7486
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct00489827 at ClinicalTrials.govDocuments that mention this clinical trial
GLUTAMICS—a randomized clinical trial on glutamate infusion in 861 patients undergoing surgery for acute coronary syndrome
https://doi.org/10.1016/j.jtcvs.2012.05.066
Preoperative NT-proBNP independently predicts outcome in patients with acute coronary syndrome undergoing CABG*
https://doi.org/10.3109/14017431.2012.731518
The impact of glutamate infusion on postoperative NT-proBNP in patients undergoing coronary artery bypass surgery: a randomized study
https://doi.org/10.1186/s12967-020-02351-7
-
Funding
Funding for this research was provided by:
Hjärt-Lungfonden (20030595, 20140633)
Region Östergötland (LIO-443891, LIO-693091)
- License Information
-
More Information
Article History
Received: 18 November 2019
Accepted: 25 April 2020
First Online: 11 May 2020
Ethics approval and consent to participate
: The Regional Ethical Review Board in Linköping, Sweden (original protocol no M76-05; addendum 26-07) approved this substudy of the GLUTAMICS trial. The study was conducted according to the Helsinki Declaration of Human Rights and all patients were enrolled in the study after written informed consent.
: Not applicable.
: The authors declare that they have no competing interests.
